Methyldopa and Enalapril Interaction

Drug interaction information between Methyldopa and Enalapril.

Methyldopa and Enalapril have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Methyldopa and Enalapril. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Methyldopa

Central Alpha-2 Agonist

Drug B

Enalapril

ACE Inhibitor

How They Interact

These medications work in different ways to lower blood pressure and have been used together without causing significant safety issues.

FDA Label Information

Other Cardiovascular Agents Enalapril maleate has been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.

Frequently Asked Questions

What SPL severity band is on file for Methyldopa + Enalapril?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Enalapril has 16 labeled pairs on file vs Methyldopa's 7. In the minor band specifically: Methyldopa has 4 (also Lithium, Colestipol, Vasopressin); Enalapril has 15 (also Spironolactone, Hydralazine, Lithium, Prazosin).

What mechanism field is on file for Methyldopa and Enalapril?

These medications work in different ways to lower blood pressure and have been used together without causing significant safety issues.

Enalapril carries more major-labeled pairs than Methyldopa

SPL source-record counts only. This page's band is minor · classes on file: Methyldopa (Central Alpha-2 Agonist); Enalapril (ACE Inhibitor).

Enalapril has 1 major-labeled pair vs Methyldopa's 0. This page itself is in the minor band, not the major band.

Methyldopa

0 major · 3 moderate · 4 minor · 7 total

Enalapril

1 major · 0 moderate · 15 minor · 16 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.